Rxn Laboratories Private Limited - Company Profile

It is a professional services private limited company based in Navi Mumbai, Maharashtra, India, established in 2016.
2016 Navi Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Rxn Laboratories Private Limited

Rxn Laboratories Private Limited, a struck off private limited company, was established on 09 January 2016 in Navi Mumbai, Maharashtra, India. Engaging in book keeping within the professional services sector, it holds CIN: U74120MH2016PTC271893. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Raja Shekhraiah Lingappa (Managing Director), Kundan Rameshwar Gupta (Managing Director), Balasaheb Shivaji Kakade (Managing Director). It is based at Plot No. 38, Ttc, Industrial Area Midc, Mahape, Navi Mumbai, Maharashtra, 400710.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74120MH2016PTC271893

  • Registration Number

    271893

  • Incorporation Date

    09 January 2016

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 1 Month
Company report

Rxn Laboratories Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rxn Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rxn Laboratories Private Limited?
Current Directors
Name Designation Appointment Date Status
Raja Shekhraiah Lingappa Managing Director 09 Jan 2016 Current
Kundan Rameshwar Gupta Managing Director 09 Jan 2016 Current
Balasaheb Shivaji Kakade Managing Director 09 Jan 2016 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rxn Laboratories.

Enhance accessibility to Rxn Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Rxn Laboratories revenue growth over time
Rxn Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rxn Laboratories?

Unlock access to Rxn Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Rxn Laboratories?

Unlock and access historical data on people associated with Rxn Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rxn Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rxn Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rxn Laboratories
Recent Activity within the Organization
  • Director Appointment

    Raja Shekhraiah Lingappa was appointed as a Managing Director was appointed as a Managing Director on 09 Jan 2016 & has been associated with this company since 10 years 1 month . was recorded as a recent event.

  • Director Appointment

    Progress on Kundan Rameshwar Gupta was appointed as a Managing Director was appointed as a Managing Director on 09 Jan 2016 & has been associated with this company since 10 years 1 month . was documented.

  • Director Appointment

    Progress on Balasaheb Shivaji Kakade was appointed as a Managing Director was appointed as a Managing Director on 09 Jan 2016 & has been associated with this company since 10 years 1 month . was documented.

  • Company Incorporation

    The activity Rxn Laboratories Private Limited was registered on 09 Jan 2016 with Roc Mumbai & aged 10 years 1 month as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rxn Laboratories Private Limited?

The CIN of Rxn Laboratories Private Limited is U74120MH2016PTC271893.

Where is Rxn Laboratories Private Limited headquartered?

Rxn Laboratories Private Limited is headquartered at Plot No. 38, Ttc, Industrial Area Midc, Mahape, Navi Mumbai, Maharashtra, 400710.

When was Rxn Laboratories Private Limited incorporated?

Rxn Laboratories Private Limited was incorporated on 09 January 2016.

Who are the current directors of Rxn Laboratories Private Limited?

The current directors of Rxn Laboratories Private Limited are

What is the primary industry of Rxn Laboratories Private Limited?

The primary industry of Rxn Laboratories Private Limited is Professional Services.

Is Rxn Laboratories Private Limited a listed company?

Rxn Laboratories Private Limited is unlisted.

What is the capital structure of Rxn Laboratories Private Limited?

The authorized capital of Rxn Laboratories Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available